| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |